Amidst the growing concerns about the spread of the Ebola virus, a company in Japan is offering what could be the solution. A drug that has been widely used in Japan against the flu is also being used as an experimental Ebola treatment, and apparently it is expected to do a good job. Given the fatality rate of Ebola it comes as no surprise that doctors want to try anything they can to treat it.

The World Health Organization is hopeful that this drug will work against Ebola, but they say they’re not putting all their eggs in this one basket. If it does in fact work against Ebola it will only be a matter of time before it can be distributed as needed. In addition to experimental trials the company behind the product is also working to have it clinically tested and approved for human use against Ebola, so that in the future it can actually be used as a full force drug.

Whether or not this drug will work is yet to be seen, but many experts are hopeful that it might work. At this point any sign of hope is a good thing and doctors say this is the most promising step in the past few months. Experimental treatments are beginning soon so it is only a matter of time before we know if it is actually going to work.

A number of drugs that are currently used to treat diabetes has been going through studies and trials recently to determine if they have any additional medical value and according to a report released this week it looks like they might just be the next big thing in cancer treatment. The drugs are all very similar in the way they work and while they’re approved for use, the FDA keeps very tight restrictions on their usage for patients. Due to a number of preliminary studies many medical experts felt that these drugs could have an impact on cancer risk and now they’ve concluded that the drugs do in fact lower the risk of developing cancer in women.

Essentially according to doctors the drugs increase the body’s sensitivity to insulin which can reduce the risk for diabetes, since diabetes is often followed by cancer they believed this could have an impact on cancer development. After months of studies the reports concluded that the drugs did in fact have a measurable impact on cancer rates in women. Obviously it’ll be quite a while before anything like this could become a real, usable treatment, but many doctors are hopeful that this is a step in the right direction for cancer testing.

This week a major committee from the World Health Organization announced that they’re working on developing a number of much needed improvements for the healthcare industry. As of now there isn’t really any sort of drug quality tracking system or screening system and that could lead to large quantities of tainted or incorrect drugs making it onto the open market.

This is exactly what the World Health Organization committee plans to resolve through some sort of new system. The details are still being worked on but they are committed to getting it setup and ready to be implemented sometime in the coming year. This is great news for everyone because it will finally put a much needed safety check on the drug manufacturing and distribution system worldwide.

The world is being done largely with help from the United States Food and Drug Administration, since they already operate a very similar system in the United States. Hopefully with the FDA’s help there will be an effective and efficient worldwide system to help keep consumers safe. It is only a matter of time before the system is completed and once it is the World Health Organization plans to implement it completely to help protection billions of people worldwide.

Epilepsy affects a significant number of people around the globe, many of which are young children. Unfortunately for years now there has been no approved medication for children under the age of 12, but today that has all changed thanks to the FDA’s approval of Fycompa.

Fycompa has been in testing for years and now that it has received FDA approval it will finally be on the market for doctors to prescribe. The medication showed a very significant reduction in symptoms and seizures for children under 12 years old, which is precisely what lead to the eventual approval of the drug. Doctors and researchers have been pushing for Fycompa’s approval for quite some time now and now that it has finally been approved it will likely be available in the very near future.

This is absolutely great news for parents of children with epilepsy as it might finally be the medication they’ve been waiting for. It is not often that a major drug breakthrough comes around and this might be a very big deal for millions of people. In the coming months doctors are expected to continue reporting on the effectiveness and success of the drug with real world patients. Doctors are incredibly happy with the FDA’s approval and are hopeful that it will perform as well in the real world as it has in testing.